Head-to-head · WeighScore
CoreAge Rx vs yourEra
The verdict
CoreAge Rx takes it — 89.5/100 to 83.8/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | yourEra |
|---|---|---|
| WeighScore | 89.5/100 | 83.8/100 |
| Grade | B+ | B |
| Site position | #1 | #8 |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $149/mo | $299/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #1 · B+
Strengths
- Advertises the same medication price at every dose
- Semaglutide and tirzepatide injection options
- No membership fee; standard prescription shipping included unless checkout states otherwise
Where it loses points
- Compounded only; no FDA-approved brand option listed
- Dispensing pharmacy not identified on the reviewed product pages
- Applicable $50–$100 consultation fee is nonrefundable after review begins
- Orders become final after approval and pharmacy transmission; 30-day refund cutoff also applies
Site position #8 · B
Strengths
- Transparent, publicly listed pricing — many compounded competitors hide price behind a quiz
- Both semaglutide and tirzepatide, not a single-drug menu, plus NAD+ and microdosing lines
- Markets a 50-state licensed-clinician network; no insurance required, HSA/FSA accepted
- Optional yourEra Optimum membership adds 1:1 coaching, a nutritionist, at-home lab draws and wearables
Where it loses points
- Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
- Mid-market pricing ($199 sema / $299 tirz) — above the cheapest compounders
- No brand-name lane and no oral route — weekly injectable only
- Thin independent footprint; the 50-state and efficacy claims are self-reported
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.